278 related articles for article (PubMed ID: 27540380)
1. Mutual Interference between Cytomegalovirus and Reconstitution of Protective Immunity after Hematopoietic Cell Transplantation.
Reddehase MJ
Front Immunol; 2016; 7():294. PubMed ID: 27540380
[TBL] [Abstract][Full Text] [Related]
2. Parameters determining the efficacy of adoptive CD8 T-cell therapy of cytomegalovirus infection.
Ebert S; Podlech J; Gillert-Marien D; Gergely KM; Büttner JK; Fink A; Freitag K; Thomas D; Reddehase MJ; Holtappels R
Med Microbiol Immunol; 2012 Nov; 201(4):527-39. PubMed ID: 22972232
[TBL] [Abstract][Full Text] [Related]
3. Reconstitution of CD8 T Cells Protective against Cytomegalovirus in a Mouse Model of Hematopoietic Cell Transplantation: Dynamics and Inessentiality of Epitope Immunodominance.
Holtappels R; Lemmermann NA; Podlech J; Ebert S; Reddehase MJ
Front Immunol; 2016; 7():232. PubMed ID: 27379095
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus-Associated Inhibition of Hematopoiesis Is Preventable by Cytoimmunotherapy With Antiviral CD8 T Cells.
Renzaho A; Podlech J; Kühnapfel B; Blaum F; Reddehase MJ; Lemmermann NAW
Front Cell Infect Microbiol; 2020; 10():138. PubMed ID: 32373544
[TBL] [Abstract][Full Text] [Related]
5. Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with 'humanized' antigen presentation as a new preclinical study tool.
Lemmermann NA; Reddehase MJ
Med Microbiol Immunol; 2016 Dec; 205(6):549-561. PubMed ID: 27539576
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus Infection.
Gergely KM; Podlech J; Becker S; Freitag K; Krauter S; Büscher N; Holtappels R; Plachter B; Reddehase MJ; Lemmermann NAW
Front Immunol; 2021; 12():694588. PubMed ID: 34489940
[TBL] [Abstract][Full Text] [Related]
7. Insufficient Antigen Presentation Due to Viral Immune Evasion Explains Lethal Cytomegalovirus Organ Disease After Allogeneic Hematopoietic Cell Transplantation.
Holtappels R; Schader SI; Oettel O; Podlech J; Seckert CK; Reddehase MJ; Lemmermann NAW
Front Cell Infect Microbiol; 2020; 10():157. PubMed ID: 32351904
[TBL] [Abstract][Full Text] [Related]
8. Modulation of cytomegalovirus immune evasion identifies direct antigen presentation as the predominant mode of CD8 T-cell priming during immune reconstitution after hematopoietic cell transplantation.
Holtappels R; Büttner JK; Freitag K; Reddehase MJ; Lemmermann NA
Front Immunol; 2024; 15():1355153. PubMed ID: 38426094
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of Antigen Presentation by Deletion of Viral Immune Evasion Genes Prevents Lethal Cytomegalovirus Disease in Minor Histocompatibility Antigen-Mismatched Hematopoietic Cell Transplantation.
Gezinir E; Podlech J; Gergely KM; Becker S; Reddehase MJ; Lemmermann NAW
Front Cell Infect Microbiol; 2020; 10():279. PubMed ID: 32582572
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy of cytomegalovirus infection by low-dose adoptive transfer of antiviral CD8 T cells relies on substantial post-transfer expansion of central memory cells but not effector-memory cells.
Holtappels R; Becker S; Hamdan S; Freitag K; Podlech J; Lemmermann NA; Reddehase MJ
PLoS Pathog; 2023 Nov; 19(11):e1011643. PubMed ID: 37972198
[TBL] [Abstract][Full Text] [Related]
11. Mouse Model of Cytomegalovirus Disease and Immunotherapy in the Immunocompromised Host: Predictions for Medical Translation that Survived the "Test of Time".
Reddehase MJ; Lemmermann NAW
Viruses; 2018 Dec; 10(12):. PubMed ID: 30563202
[TBL] [Abstract][Full Text] [Related]
12. Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation.
Borchers S; Luther S; Lips U; Hahn N; Kontsendorn J; Stadler M; Buchholz S; Diedrich H; Eder M; Koehl U; Ganser A; Mischak-Weissinger E
Transpl Infect Dis; 2011 Jun; 13(3):222-36. PubMed ID: 21585633
[TBL] [Abstract][Full Text] [Related]
13. Memory CD8 T Cells Protect against Cytomegalovirus Disease by Formation of Nodular Inflammatory Foci Preventing Intra-Tissue Virus Spread.
Holtappels R; Podlech J; Freitag K; Lemmermann NA; Reddehase MJ
Viruses; 2022 May; 14(6):. PubMed ID: 35746617
[TBL] [Abstract][Full Text] [Related]
14. Mast cells: innate attractors recruiting protective CD8 T cells to sites of cytomegalovirus infection.
Podlech J; Ebert S; Becker M; Reddehase MJ; Stassen M; Lemmermann NA
Med Microbiol Immunol; 2015 Jun; 204(3):327-34. PubMed ID: 25648117
[TBL] [Abstract][Full Text] [Related]
15. Antigen presentation under the influence of 'immune evasion' proteins and its modulation by interferon-gamma: implications for immunotherapy of cytomegalovirus infection with antiviral CD8 T cells.
Fink A; Lemmermann NA; Gillert-Marien D; Thomas D; Freitag K; Böhm V; Wilhelmi V; Reifenberg K; Reddehase MJ; Holtappels R
Med Microbiol Immunol; 2012 Nov; 201(4):513-25. PubMed ID: 22961126
[TBL] [Abstract][Full Text] [Related]
16. Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation.
Lugthart G; van Ostaijen-Ten Dam MM; Jol-van der Zijde CM; van Holten TC; Kester MG; Heemskerk MH; Bredius RG; van Tol MJ; Lankester AC
Biol Blood Marrow Transplant; 2014 May; 20(5):655-61. PubMed ID: 24462981
[TBL] [Abstract][Full Text] [Related]
17. Evidence against a key role for transforming growth factor-beta1 in cytomegalovirus-induced bone marrow aplasia.
Dobonici M; Podlech J; Steffens HP; Maiberger S; Reddehase MJ
J Gen Virol; 1998 Apr; 79 ( Pt 4)():867-76. PubMed ID: 9568983
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus inhibits the engraftment of donor bone marrow cells by downregulation of hemopoietin gene expression in recipient stroma.
Steffens HP; Podlech J; Kurz S; Angele P; Dreis D; Reddehase MJ
J Virol; 1998 Jun; 72(6):5006-15. PubMed ID: 9573270
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.
Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P
J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow failure by cytomegalovirus is associated with an in vivo deficiency in the expression of essential stromal hemopoietin genes.
Mayer A; Podlech J; Kurz S; Steffens HP; Maiberger S; Thalmeier K; Angele P; Dreher L; Reddehase MJ
J Virol; 1997 Jun; 71(6):4589-98. PubMed ID: 9151853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
